Article
The potential of fetal cell therapy for osteogenesis imperfecta using placenta derived stem cells
2013-01-01
Abstract excerpt
Human mesenchymal stromal/stem cells (MSC) isolated from aborted first trimester fetal bone marrow (BM) hold promise for use in tissue engineering applications and cell-based therapies due to their advantageous characteristics compared to their adult BM-MSC counterparts; faster growth kinetics, active telomerase, smaller size and higher differentiation potency. However, their isolation is restricted ethically and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d3d59d70-ff1e-5a62-bc23-bf1fd39f4d0a
- DOI
- 10.25560/40291
